Revvity, Inc. has unveiled Signals Xynthetica, an AI models-as-a-service platform linking in-silico molecular and materials design with wet-lab data, enabling scientists to predict, test, and optimize ...

Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...

MANCHESTER, N.H., Sept. 30, 2024 /PRNewswire/ -- BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has ...

Adjuvant Therapy for Renal Cell Carcinoma: End Points, Outcomes, and Risk Assessments Adaptive clinical trials use algorithms to predict, during the study, patient outcomes and final study results.

The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...

Advances in mechanistic modeling, machine learning, and biomedical data integration are making it possible to move beyond “one-size-fits-all” evidence and ...

Basket and umbrella studies as well as adaptive enrichment design strategies represent novel approaches to testing targeted therapeutics in oncology, and a session at ASCO's annual meeting discussed ...

A study led by researchers at the Institute for Research in Biomedicine of Lleida (IRBLleida), the University of Lleida (UdL) ...